leisure time -WSS

leisure time

author：fashion 2025-08-28 08:47:01 - browse：88

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies.

Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023. Each of the three niches continue to generate buzz among investors, even as other areas fizzle.

It’s not that those three industries are perfect fits for private equity, it’s that the more obvious areas like autism therapists and physician practices are struggling with high interest rates and regulatory scrutiny, said Rebecca Springer, PitchBook’s lead health care analyst.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： ADCs take center stage as promising cancer treatments

knowledge

WSS

Texas Medical Board asked to define abortion emergency exception

Top private equity targets in 2023: cardiology, clinical trials, lasers

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Readout Newsletter: Amgen, Regeneron, BGI Group and more

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

STAT Readout: Friday, Oct. 20 biotech updates

entertainment

leisure time

explore

Anesthesiologist group: stop taking Ozempic before surgery

J&J lung cancer data amount to new salvo against AstraZeneca

Walensky prepares to leave CDC — and Congress — behind

Readout LOUD podcast: Live from the 2023 STAT Summit

Medicare details structure of new drug price negotiation program

Medicare Advantage plans can’t deny care with AI, CMS warns

State Dept. review finds Biden bears some blame for Afghanistan failures

FDA clears Verve to begin U.S. study of gene

Cancer drug shortages should be causing more outrage

Global cancer cases to surge 77% by 2050, WHO report says

hotspot

CZI to create biohub to build anti

Padmanee Sharma of MD Anderson at center of lawsuit over credit

FDA clears Verve to begin U.S. study of gene

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

CZI to create biohub to build anti

knowledge

knowledge

knowledge

hotspot